Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2014

Open Access 01-12-2014 | Short report

The prevalence of the metabolically healthy obese phenotype in an aging population and its association with subclinical cardiovascular disease: The Brazilian study on healthy aging

Authors: Lara Roberson, Sameer Shaharyar, Ehimen Aneni, Wladimir Freitas, Michael Blaha, Arthur Agatston, Roger Blumenthal, Raul D Santos, Hamid Feiz, Khurram Nasir, Andrei Sposito

Published in: Diabetology & Metabolic Syndrome | Issue 1/2014

Login to get access

Abstract

Background

Current literature has elucidated a new phenotype, metabolically healthy obese (MHO), with risks of cardiovascular disease similar to that of normal weight individuals. Few studies have examined the MHO phenotype in an aging population, especially in association with subclinical CVD.

Research design and methods

This cross sectional study population consisted of 208 octogenarians and older. Anthropometrics, biochemical, and radiological parameters were measured to assess obesity, metabolic health (assessed by the National Cholesterol Education Program –Adult Treatment Panel (NCEP-ATP III) criteria), and subclinical measures of CVD.

Results

The prevalence of MHO was 13.5% (N = 28). No significant association with MHO was noted for age, coronary artery calcium score, cIMT, or hs-CRP > 3 mg/dl (p = NS).

Conclusions

Our results suggest that the MHO phenotype exists in the elderly; however, subclinical CVD measures were not different in sub-group analysis suggesting traditional metabolic risk factor algorithms may not be accurate in the very elderly.
Literature
2.
go back to reference Bluher M: The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol. 2010, 21: 38-43. 10.1097/MOL.0b013e3283346ccc.CrossRefPubMed Bluher M: The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol. 2010, 21: 38-43. 10.1097/MOL.0b013e3283346ccc.CrossRefPubMed
3.
go back to reference Ortega FB, Lee DC, Katzmarzyk PT, Ruiz JR, Sui X, Church TS, Blair SN: The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J. 2013, 34: 389-397. 10.1093/eurheartj/ehs174.PubMedCentralCrossRefPubMed Ortega FB, Lee DC, Katzmarzyk PT, Ruiz JR, Sui X, Church TS, Blair SN: The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J. 2013, 34: 389-397. 10.1093/eurheartj/ehs174.PubMedCentralCrossRefPubMed
4.
go back to reference Hamer M, Stamatakis E: Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab. 2012, 97: 2482-2488. 10.1210/jc.2011-3475.PubMedCentralCrossRefPubMed Hamer M, Stamatakis E: Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab. 2012, 97: 2482-2488. 10.1210/jc.2011-3475.PubMedCentralCrossRefPubMed
5.
go back to reference Kuk JL, Ardern CI: Are metabolically normal but obese individuals at lower risk for all-cause mortality?. Diabetes Care. 2009, 32: 2297-2299. 10.2337/dc09-0574.PubMedCentralCrossRefPubMed Kuk JL, Ardern CI: Are metabolically normal but obese individuals at lower risk for all-cause mortality?. Diabetes Care. 2009, 32: 2297-2299. 10.2337/dc09-0574.PubMedCentralCrossRefPubMed
6.
go back to reference Arnlov J, Ingelsson E, Sundstrom J, Lind L: Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010, 121: 230-236. 10.1161/CIRCULATIONAHA.109.887521.CrossRefPubMed Arnlov J, Ingelsson E, Sundstrom J, Lind L: Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010, 121: 230-236. 10.1161/CIRCULATIONAHA.109.887521.CrossRefPubMed
7.
go back to reference Choi J: Obesity defined by body mass index and metabolic status in the elderly. J Korean Geriatr Soc. 2011, 15: 222-229. 10.4235/jkgs.2011.15.4.222.CrossRef Choi J: Obesity defined by body mass index and metabolic status in the elderly. J Korean Geriatr Soc. 2011, 15: 222-229. 10.4235/jkgs.2011.15.4.222.CrossRef
8.
go back to reference Mirbolouk M, Asgari S, Sheikholeslami F, Mirbolouk F, Azizi F, Hadaegh F: Different obesity phenotypes, and incident cardiovascular disease and mortality events in elderly Iranians: Tehran lipid and glucose study. Geriatr Gerontol Int. 2014, [Epub ahead of print] Mirbolouk M, Asgari S, Sheikholeslami F, Mirbolouk F, Azizi F, Hadaegh F: Different obesity phenotypes, and incident cardiovascular disease and mortality events in elderly Iranians: Tehran lipid and glucose study. Geriatr Gerontol Int. 2014, [Epub ahead of print]
9.
go back to reference Choi KM, Cho HJ, Choi HY, Yang SJ, Yoo HJ, Seo JA, Kim SG, Baik SH, Choi DS, Kim NH: Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans. Clin Endocrinol (Oxf). 2013, 79: 364-370. 10.1111/cen.12154.CrossRef Choi KM, Cho HJ, Choi HY, Yang SJ, Yoo HJ, Seo JA, Kim SG, Baik SH, Choi DS, Kim NH: Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans. Clin Endocrinol (Oxf). 2013, 79: 364-370. 10.1111/cen.12154.CrossRef
10.
go back to reference Plan and operation of the Third National Health and Nutrition Examination Survey, 1988–94. Series 1: programs and collection procedures. Vital and health statistics Ser 1, Programs and collection procedures. 1994, 1-407. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988–94. Series 1: programs and collection procedures. Vital and health statistics Ser 1, Programs and collection procedures. 1994, 1-407.
11.
go back to reference Global Recommendations on Physical Activity for Health. 2010, Worl Health Organization Global Recommendations on Physical Activity for Health. 2010, Worl Health Organization
12.
go back to reference Freitas WM, Carvalho LS, Moura FA, Sposito AC: Atherosclerotic disease in octogenarians: a challenge for science and clinical practice. Atherosclerosis. 2012, 225: 281-289. 10.1016/j.atherosclerosis.2012.06.070.CrossRefPubMed Freitas WM, Carvalho LS, Moura FA, Sposito AC: Atherosclerotic disease in octogenarians: a challenge for science and clinical practice. Atherosclerosis. 2012, 225: 281-289. 10.1016/j.atherosclerosis.2012.06.070.CrossRefPubMed
13.
go back to reference Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.
14.
go back to reference Cetin DC, Nasr G: Obesity in the elderly: more complicated than you think. Cleve Clin J Med. 2014, 81: 51-61. 10.3949/ccjm.81a.12165.CrossRefPubMed Cetin DC, Nasr G: Obesity in the elderly: more complicated than you think. Cleve Clin J Med. 2014, 81: 51-61. 10.3949/ccjm.81a.12165.CrossRefPubMed
15.
go back to reference Malik S, Budoff MJ, Katz R, Blumenthal RS, Bertoni AG, Nasir K, Szklo M, Barr RG, Wong ND: Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis. Diabetes Care. 2011, 34: 2285-2290. 10.2337/dc11-0816.PubMedCentralCrossRefPubMed Malik S, Budoff MJ, Katz R, Blumenthal RS, Bertoni AG, Nasir K, Szklo M, Barr RG, Wong ND: Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis. Diabetes Care. 2011, 34: 2285-2290. 10.2337/dc11-0816.PubMedCentralCrossRefPubMed
16.
go back to reference Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation. 1998, 97: 1837-1847. 10.1161/01.CIR.97.18.1837.CrossRefPubMed Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation. 1998, 97: 1837-1847. 10.1161/01.CIR.97.18.1837.CrossRefPubMed
17.
go back to reference Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR: The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med. 2008, 168: 1617-1624. 10.1001/archinte.168.15.1617.CrossRefPubMed Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR: The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med. 2008, 168: 1617-1624. 10.1001/archinte.168.15.1617.CrossRefPubMed
18.
go back to reference Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD: Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol. 2005, 46: 158-165. 10.1016/j.jacc.2005.02.088.CrossRefPubMed Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD: Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol. 2005, 46: 158-165. 10.1016/j.jacc.2005.02.088.CrossRefPubMed
19.
go back to reference Kennedy J, Shavelle R, Wang S, Budoff M, Detrano RC: Coronary calcium and standard risk factors in symptomatic patients referred for coronary angiography. Am Heart J. 1998, 135: 696-702. 10.1016/S0002-8703(98)70288-1.CrossRefPubMed Kennedy J, Shavelle R, Wang S, Budoff M, Detrano RC: Coronary calcium and standard risk factors in symptomatic patients referred for coronary angiography. Am Heart J. 1998, 135: 696-702. 10.1016/S0002-8703(98)70288-1.CrossRefPubMed
20.
go back to reference Kondos GT, Hoff JA, Sevrukov A, Daviglus ML, Garside DB, Devries SS, Chomka EV, Liu K: Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation. 2003, 107: 2571-2576. 10.1161/01.CIR.0000068341.61180.55.CrossRefPubMed Kondos GT, Hoff JA, Sevrukov A, Daviglus ML, Garside DB, Devries SS, Chomka EV, Liu K: Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation. 2003, 107: 2571-2576. 10.1161/01.CIR.0000068341.61180.55.CrossRefPubMed
21.
go back to reference Taylor AJ, Feuerstein I, Wong H, Barko W, Brazaitis M, O'Malley PG: Do conventional risk factors predict subclinical coronary artery disease? Results from the Prospective Army Coronary Calcium Project. Am Heart J. 2001, 141: 463-468. 10.1067/mhj.2001.113069.CrossRefPubMed Taylor AJ, Feuerstein I, Wong H, Barko W, Brazaitis M, O'Malley PG: Do conventional risk factors predict subclinical coronary artery disease? Results from the Prospective Army Coronary Calcium Project. Am Heart J. 2001, 141: 463-468. 10.1067/mhj.2001.113069.CrossRefPubMed
22.
go back to reference Newman AB, Naydeck BL, Sutton-Tyrrell K, Feldman A, Edmundowicz D, Kuller LH: Coronary artery calcification in older adults to age 99: prevalence and risk factors. Circulation. 2001, 104: 2679-2684. 10.1161/hc4601.099464.CrossRefPubMed Newman AB, Naydeck BL, Sutton-Tyrrell K, Feldman A, Edmundowicz D, Kuller LH: Coronary artery calcification in older adults to age 99: prevalence and risk factors. Circulation. 2001, 104: 2679-2684. 10.1161/hc4601.099464.CrossRefPubMed
23.
go back to reference Bots ML, Launer LJ, Lindemans J, Hofman A, Grobbee DE: Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: the Rotterdam Study. J Intern Med. 1997, 242: 339-347. 10.1046/j.1365-2796.1997.00239.x.CrossRefPubMed Bots ML, Launer LJ, Lindemans J, Hofman A, Grobbee DE: Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: the Rotterdam Study. J Intern Med. 1997, 242: 339-347. 10.1046/j.1365-2796.1997.00239.x.CrossRefPubMed
24.
go back to reference Gale CR, Ashurst HE, Powers HJ, Martyn CN: Antioxidant vitamin status and carotid atherosclerosis in the elderly. Am J Clin Nutr. 2001, 74: 402-408.PubMed Gale CR, Ashurst HE, Powers HJ, Martyn CN: Antioxidant vitamin status and carotid atherosclerosis in the elderly. Am J Clin Nutr. 2001, 74: 402-408.PubMed
25.
go back to reference Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC: Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000, 132: 270-278.CrossRefPubMed Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC: Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000, 132: 270-278.CrossRefPubMed
26.
go back to reference Muller M, van den Beld AW, Bots ML, Grobbee DE, Lamberts SW, van der Schouw YT: Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation. 2004, 109: 2074-2079. 10.1161/01.CIR.0000125854.51637.06.CrossRefPubMed Muller M, van den Beld AW, Bots ML, Grobbee DE, Lamberts SW, van der Schouw YT: Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation. 2004, 109: 2074-2079. 10.1161/01.CIR.0000125854.51637.06.CrossRefPubMed
27.
go back to reference Moura FA, Freitas WM, Sposito AC: Emergent cardiovascular risk factors in the very elderly. Expert Rev Cardiovasc Ther. 2012, 10: 1221-1225. 10.1586/erc.12.98.CrossRefPubMed Moura FA, Freitas WM, Sposito AC: Emergent cardiovascular risk factors in the very elderly. Expert Rev Cardiovasc Ther. 2012, 10: 1221-1225. 10.1586/erc.12.98.CrossRefPubMed
28.
go back to reference Alibhai SM, Greenwood C, Payette H: An approach to the management of unintentional weight loss in elderly people. Can Med Assoc J. 2005, 172: 773-780. 10.1503/cmaj.1031527.CrossRef Alibhai SM, Greenwood C, Payette H: An approach to the management of unintentional weight loss in elderly people. Can Med Assoc J. 2005, 172: 773-780. 10.1503/cmaj.1031527.CrossRef
29.
go back to reference Douketis JD, Paradis G, Keller H, Martineau C: Canadian guidelines for body weight classification in adults: application in clinical practice to screen for overweight and obesity and to assess disease risk. Can Med Assoc J. 2005, 172: 995-998. 10.1503/cmaj.045170.CrossRef Douketis JD, Paradis G, Keller H, Martineau C: Canadian guidelines for body weight classification in adults: application in clinical practice to screen for overweight and obesity and to assess disease risk. Can Med Assoc J. 2005, 172: 995-998. 10.1503/cmaj.045170.CrossRef
Metadata
Title
The prevalence of the metabolically healthy obese phenotype in an aging population and its association with subclinical cardiovascular disease: The Brazilian study on healthy aging
Authors
Lara Roberson
Sameer Shaharyar
Ehimen Aneni
Wladimir Freitas
Michael Blaha
Arthur Agatston
Roger Blumenthal
Raul D Santos
Hamid Feiz
Khurram Nasir
Andrei Sposito
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2014
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-6-121

Other articles of this Issue 1/2014

Diabetology & Metabolic Syndrome 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.